Showing 281 - 300 results of 393 for search '(( 10 ((meet decrease) OR (((nn decrease) OR (mean decrease)))) ) OR ( 12 c decrease ))*', query time: 0.17s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294
  15. 295

    Antiferromagnetism in EuPdGe3 by Albedah, M.A.

    Published 2014
    “…EuPdGe3 crystallizes in the BaNiSn3-type tetragonal structure (space group I4mm) with the lattice constants a=4.4457(1)Å and c=10.1703(2)Å. The results are consistent with EuPdGe3 being an antiferromagnet with the Néel temperature TN=12.16(1)K and with the Eu spins S=7/2 in the ab plane. …”
    Get full text
    Get full text
  16. 296
  17. 297

    Hypospadias Reconstruction Training: Development of an Ex-Vivo Model for Objective Evaluation of Surgical Skills by Abbas, Tariq

    Published 2025
    “…However, EMG measurements showed significant reductions in average EMG power, total time, dominant frequency, and cumulative muscle workload after training. Additionally, the mean power spectral density of the EMG signal decreased notably post-training. …”
    Get full text
    Get full text
    Get full text
    article
  18. 298

    Trends and Appropriateness of Sodium-glucose Co-transporter 2 Inhibitors Use in Qatar by Zaghloul, Nancy

    Published 2023
    “…Male gender (odds ratio [OR], 1.692; 95% confidence interval [CI], 1.015 to 2.822; P=0.044), patients with a baseline glycated hemoglobin (HbA1c) >7% (OR, 3.219; 95% CI, 1.838 to 5.637; P<0.001) and atherosclerotic cardiovascular disease (ASCVD) (OR, 2.182; 95% CI, 1.053 to 4.523), patients on metformin (OR, 7.556; 95% CI, 4.460 to 12.802; P<0.001), sulfonylureas (OR, 2.301; 95% CI, 1.160 to 4.563; P=0.017), and dipeptidyl peptidase 4 inhibitors (DPP4is) (OR, 3.430; 95% CI, 2.004 to 5.871; P<0.001) were more likely to be prescribed a SGLT2i. …”
    Get full text
  19. 299
  20. 300